Maria Tretiakova

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• 845 Diagnostic Utility of CD56 in the Immunohistochemical Assessment of Eosinophilic Vacuolated Tumor

  Laboratory Investigation · 2026-03-01

• 765 Diagnostic Utility of VSTM2A RNA-ISH in Mucinous Tubular and Spindle Cell Carcinomas: Results from a 331-Tumor Validation Cohort

  Laboratory Investigation · 2026-03-01

• 846 Eosinophilic Vacuolated Tumor with Worrisome Morphologic Features May Have Metastatic Potential

  Laboratory Investigation · 2026-03-01

• Series of renal cell carcinomas with TFE3 overexpression by copy number gains and without TFE3 gene rearrangement

  Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2025-11-10

• Comparison of glass‐based and whole‐slide image‐based grade assignment for clear‐cell and papillary renal cell carcinoma: a multi‐cohort, international reproducibility study

  Histopathology · 2025-10-31 · 1 citations

• Sex and smoking bias in the selection of somatic mutations in human bladder

  Nature · 2025-10-08 · 13 citations

• DNA Methylation-Based Classification of Kidney Neoplasms

  Modern Pathology · 2025-09-11 · 1 citations

• Agreement between transurethral resection of bladder tumor and radical cystectomy pathology in patients with bladder cancer subtype histology: A retrospective cohort study

  Urologic Oncology Seminars and Original Investigations · 2025-09-02 · 2 citations

• Figure 1 from Patterns of HER2 Expression in Metastatic Prostate and Urothelial Cancers: Implications for HER2-Targeted Therapies

  2025-08-25

• Figure 2 from Patterns of HER2 Expression in Metastatic Prostate and Urothelial Cancers: Implications for HER2-Targeted Therapies

  2025-08-25

• Figure S1 from Patterns of HER2 Expression in Metastatic Prostate and Urothelial Cancers: Implications for HER2-Targeted Therapies

  2025-08-25

• Table 1 from Patterns of HER2 Expression in Metastatic Prostate and Urothelial Cancers: Implications for HER2-Targeted Therapies

  2025-08-25

• Supplementary Table 1 from Patterns of HER2 Expression in Metastatic Prostate and Urothelial Cancers: Implications for HER2-Targeted Therapies

  2025-08-25

• Figure S2 from Patterns of HER2 Expression in Metastatic Prostate and Urothelial Cancers: Implications for HER2-Targeted Therapies

  2025-08-25

• Supplementary Table 2 from Patterns of HER2 Expression in Metastatic Prostate and Urothelial Cancers: Implications for HER2-Targeted Therapies

  2025-08-25

• Data from Patterns of HER2 Expression in Metastatic Prostate and Urothelial Cancers: Implications for HER2-Targeted Therapies

  2025-08-25

• Figure 3 from Patterns of HER2 Expression in Metastatic Prostate and Urothelial Cancers: Implications for HER2-Targeted Therapies

  2025-08-25

• Overlapping Morphologic and Immunophenotypic Features of Plasmacytoid Urothelial Carcinoma and Urothelial Carcinoma With Osteoclast-Like Giant Cells

  International Journal of Surgical Pathology · 2025-08-19 · 2 citations

• Patterns of HER2 Expression in Metastatic Prostate and Urothelial Cancers: Implications for HER2-Targeted Therapies

  Cancer Research Communications · 2025-08-01 · 5 citations

• Interobserver Reproducibility of Pelvicalyceal Invasion in Renal Cell Carcinoma Nephrectomies Among Genitourinary Pathologists

  The American Journal of Surgical Pathology · 2025-07-25